The Flowr Corporation

TSXV:FLWR.H Stock Report

Market Cap: CA$10.7m

Flowr Past Earnings Performance

Past criteria checks 0/6

Flowr's earnings have been declining at an average annual rate of -49.7%, while the Pharmaceuticals industry saw earnings growing at 27.3% annually. Revenues have been growing at an average rate of 44.1% per year.

Key information

-49.7%

Earnings growth rate

-20.8%

EPS growth rate

Pharmaceuticals Industry Growth23.1%
Revenue growth rate44.1%
Return on equity-740.2%
Net Margin-762.8%
Last Earnings Update30 Sep 2022

Recent past performance updates

Recent updates

Flowr's (CVE:FLWR) Stock Price Has Reduced 79% In The Past Year

Jan 18
Flowr's (CVE:FLWR) Stock Price Has Reduced 79% In The Past Year

The Flowr Corporation (CVE:FLWR) Analysts Are More Bearish Than They Used To Be

Nov 26
The Flowr Corporation (CVE:FLWR) Analysts Are More Bearish Than They Used To Be

How Many The Flowr Corporation (CVE:FLWR) Shares Did Insiders Buy, In The Last Year?

Jul 21
How Many The Flowr Corporation (CVE:FLWR) Shares Did Insiders Buy, In The Last Year?

Revenue & Expenses Breakdown

How Flowr makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSXV:FLWR.H Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2212-95131
30 Jun 2213-99151
31 Mar 2212-84141
31 Dec 2112-86162
30 Sep 2110-118152
30 Jun 2110-120161
31 Mar 2110-122191
31 Dec 208-126221
30 Sep 206-47261
30 Jun 204-53311
31 Mar 204-36351
31 Dec 195-31331
30 Sep 198-14310
30 Jun 197-4260
31 Mar 194-19200
31 Dec 183-15150
30 Sep 180-11100
30 Jun 180-670
31 Mar 180-440
31 Dec 170-230

Quality Earnings: FLWR.H is currently unprofitable.

Growing Profit Margin: FLWR.H is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: FLWR.H is unprofitable, and losses have increased over the past 5 years at a rate of 49.7% per year.

Accelerating Growth: Unable to compare FLWR.H's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: FLWR.H is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (109.7%).


Return on Equity

High ROE: FLWR.H has a negative Return on Equity (-740.24%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies